Events

Berlin, Germany
|
March 19-21

The program will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring, and biomarker development.

At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals, and the pharmaceutical industry.

Boston, MA
|
March 20-22

CAR-T Congress USA gathers 100+ thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors.

Hear from 25+ industry leaders including Ziopharm, Merck KGaA, GSK, Dana Farber, Celgene and leading research institutions to discuss the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, how to improve patient access, the development of an ‘off-the-shelf’ product and commercializing this new cell therapy.

As a reader of ACIR, you will also benefit from an exclusive 10% discount, simply quote ACIR10 on registering.

*Update: The ACIR team attended several talks at the conference. You can read our coverage here.

Chicago, IL
|
April 14-18

Presentations at the Annual Meeting will cover the latest basic, translational, clinical, and prevention-focused research in the field, including important areas such as early detection, cancer interception, and survivorship in all populations. We will feature new sessions on cancer health disparities that have been inspired by one of the important AACR presidential initiatives. We will also be reprising a popular new feature from Annual Meeting 2017, “Unsolved Mysteries,” featuring provocative questions and their in-depth discussion by speakers and members of the audience.

*Update: The ACIR team attended several talks at the conference. You can read our coverage here.

Boston, MA
|
May 8-9

The Cancer Microbiome Congress will bring together academics, physicians, senior pharma executives and biotechs to learn about the developments and network to improve treatments in future. The speakers presenting at the congress include David Cook from Seres Therapeutics, the first company to develop live microbial therapeutics and Vancheswaran "Deepak" Gopalakrishnan from MD Anderson who published the groundbreaking paper identifying how the gut microbiome influences responses to Anti-PD1-Therapy. See the agenda for the Congress here.

As a reader of ACIR, you will also benefit from an exclusive 10% discount, simply quote ACIR10 on registering.

Mainz, Germany
|
May 15-17

The CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT 2018 invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

Plenary sessions will range from pre-clinical research to clinical development on the topics of therapeutic vaccination, cellular therapy, improving immunity, tumor microenvironment, antibodies, regulatory research and immunoguiding. There will also be a poster exhibit and selected poster short talk sessions, as well as industry symposia and industry exhibits.

Chicago, IL
|
May 16-19

The mission of ASGCT to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.

London, UK
|
May 24-25

The 3rd Annual Advances in Immuno-Oncology Congress features over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate.

Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.

Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more.

To register using ACIR 20% discount contact a.fernandez@oxfordglobal.co.uk and quote IMMUNO20

London, Ontario, Canada
|
June 1-4

The Canadian Society for Immunology (CSI) is an organization that fosters and supports Immunology research throughout Canada. Founded in 1966, the society provides a focal point for Canadian Immunology by organizing an annual spring meeting that alternates between the west and the east of the country. One of the highlights of the annual meeting is the Cinader Award lecture, named in honor of Hardi Cinader, a founding member of CSI and its first president.

Chicago, IL
|
June 1-5

The Annual Meeting brings together more than 32,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.

Basel Switzerland
|
June 24-26

During this Cell Symposium, you will hear about the latest advances in immunometabolism from physician-scientists, basic researchers and industry leaders. We will discuss how local and systemic metabolism are integrated at the cellular level to regulate immune cell function and we will focus on how novel insights into immunometabolism can be harnessed to advance and/or bolster therapeutic interventions in metabolic diseases, inflammation, autoimmunity, and cancer.

Amsterdam, Netherlands
|
June 30-July 3

The theme of the Congress is ‘From Fundamental Insight to Rational Cancer Treatment’, covering the journey of discovery and development ‘from bench to bedside’. The Congress will feature world-class speakers discussing the most innovative current research topics, including a special education track aimed at clinicians. As well as high-profile plenary sessions, the program offers parallel symposia, allowing participants to build their own scientific program according to their interests.

Kyoto, Japan
|
July 10-12

The 6th JCA-AACR special joint conference will bring together basic scientists and clinical researchers from the United States and Japan, and around the world, to share the latest and more exciting developments in lung cancer research. Session topics will include: Novel Immunotherapy Strategies beyond PD-1/PD-L1; Primary and Acquired Mechanisms of Resistance to Immunotherapies; Tumor Microenvironment and Implications for Treatment.

Boston, MA
|
August 27-31

Join over 600 thought leaders at industry’s leading Immuno-Oncology event and learn about the latest research in a comprehensive 5-day, 12-track program, network and build lasting collaborations with an international mix of delegates from industry and academia, and gain actionable solutions to drive your organization’s next-generation immunotherapy programs.

Madrid, Spain
|
September 13-15

The International Conference on Lymphocyte Engineering (ICLE 2018) will provide a dedicated platform to advance research, clinical translation and treatment in immuno-gene therapy. ICLE brings together immunotherapy with cell and gene therapy to foster interdisciplinary collaborations, deepening the connection between basic and clinical research across related disease specialties: oncology, pathogenic diseases, autoimmunity, immunodeficiencies and others.

San Diego, CA
|
September 17-18

Conference deals with the diagnosis, prevention, and treatment of diseases of the organ specific cancers and including the latest techniques. It is an event designed for International medical health professionals and oncologists to facilitate the dissemination and application of research findings related to Cancer. It provides two days of robust discussions on methods and strategies related to management and quality improvement of Cancer therapy, Tumor Biomarkers as well as explore new ideas and concepts on a global scale and the topics include breast cancer, leukaemia, bone cancer, lung cancer, prostate cancer, thyroid cancer, blood cancer, colon cancer and cervical cancer.

Sao Paulo, Brazil
|
September 27-29

In cooperation with LAGOS, the conference will present an overview of state-of-the-art translational cancer research. It will explore the latest discoveries in targeted therapies and drug resistance, cancer immunology, drug discovery, and the most common cancers in the region. The session topics will include Immune Checkpoints and The Microbiome and Cancer.

New York, NY
|
September 30-October 3

The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to present this program. It will feature talks from more than 60 leaders in the field, covering all areas of inquiry in cancer immunology and immunotherapy. The session topics will include Regulating T Cells and Their Response to Cancer; Tackling the Tumor Microenvironment- beyond T Cells; Genetically Engineered T Cells; Maintenance of Immune Balance: Effects of Targeted and Immune Therapies; Novel Vaccine Platforms and Combinations; Mutational Analysis and Predicting Response to Immunotherapy; Convergence of Technology and Cancer Immunotherapy; Microbiome and Metabolism.

*Update: The ACIR team attended several talks at the conference. You can read our coverage here.

San Diego, CA
|
October 11-12

Due to the success of the UK Advances in Immuno-Oncology event, Oxford Global are expanding this event to the USA. The USA Congress is the first of its kind and will feature over 20 presentations from leading heads of the Pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate.

Topic discussion ranges across a variety of therapeutic strategies, from CAR T cell therapies to microbiome in Immuno-Oncology and from assays and modelling in Immuno-Oncology to NK cell-based therapeutics.

ACIR members wanting to attend this Congress (Academic and Industry attendees only) are eligible for a 20% discount. Contact Danielle Dalby today at d.dalby@oxfordglobal.co.uk and quote IMMUNO20.

Miami, FL
|
November 27-30

This AACR special conference is designed to integrate multi-disciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. This year’s program will expand our knowledge of the microbiome; metabolic regulation; oncogenic, myeloid, and vascular pathways; and targeted therapies. These world-renowned oncologists and scientist will offer new insights on systems biology, checkpoint, combination therapies, and molecular targets.

Maui, HI
|
January 30-February 2, 2019

The 2019 Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months, and feature expected advances that you and your patients will likely see in the upcoming year.

Atlanta, GA
|
March 29-April 3

The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world. More information about the AACR Annual Meeting 2019 will be available later online.